News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,445 Results
Type
Article (88188)
Company Profile (825)
Press Release (784412)
Multimedia
Podcasts (206)
Webinars (32)
Section
Business (233350)
Career Advice (4152)
Deals (39896)
Drug Delivery (156)
Drug Development (91478)
Employer Resources (205)
FDA (18438)
Job Trends (17441)
News (398133)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (191)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (379)
Approvals (18639)
Artificial intelligence (684)
Autoimmune disease (200)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (491)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (695)
Cancer (5349)
Cardiovascular disease (474)
Career advice (3579)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (40)
Clinical research (77421)
Collaboration (1960)
Company closure (5)
Compensation (1235)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (969)
Cystic fibrosis (157)
Data (6695)
Decentralized trials (2)
Denatured (76)
Depression (162)
Diabetes (556)
Diagnostics (7330)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (331)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100752)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135880)
Executive appointments (1072)
FDA (21812)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1649)
Gene editing (234)
Generative AI (71)
Gene therapy (719)
GLP-1 (1169)
Government (5482)
Grass and pollen (8)
Guidances (389)
Healthcare (20983)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (134)
Infectious disease (3323)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (99)
Layoffs (663)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (20)
Lung cancer (717)
Lymphoma (396)
Machine learning (49)
Management (66)
Manufacturing (927)
MASH (184)
Medical device (15095)
Medtech (15161)
Mergers & acquisitions (23044)
Metabolic disorders (1483)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (386)
Neuropsychiatric disorders (108)
Neuroscience (3248)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (724)
Opinion (349)
Ovarian cancer (176)
Pain (232)
Pancreatic cancer (252)
Parkinson's disease (317)
Partnered (39)
Patents (548)
Patient recruitment (555)
Peanut (65)
People (67164)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23922)
Phase 2 (33594)
Phase 3 (25310)
Pipeline (6130)
Policy (358)
Postmarket research (3554)
Preclinical (10726)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1020)
Real estate (7445)
Recruiting (81)
Regulatory (29357)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (118)
Tariffs (101)
The Weekly (128)
Vaccines (1193)
Venture capital (103)
Weight loss (495)
Women's health (105)
Worklife (23)
Date
Today (173)
Last 7 days (877)
Last 30 days (3261)
Last 365 days (32828)
2026 (5758)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51699)
Australia (9085)
California (12222)
Canada (3474)
China (1234)
Colorado (516)
Connecticut (534)
Delaware (363)
Europe (118970)
Florida (1813)
Georgia (397)
Hawaii (4)
Idaho (68)
Illinois (1022)
India (81)
Indiana (574)
Iowa (24)
Japan (470)
Kansas (135)
Kentucky (49)
Louisiana (35)
Maine (84)
Maryland (1520)
Massachusetts (8963)
Michigan (381)
Minnesota (687)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3282)
New Mexico (33)
New York (3218)
North Carolina (1687)
North Dakota (10)
Northern California (5910)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2431)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4737)
Tennessee (192)
Texas (1921)
United States (43965)
Utah (369)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1012)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
There are 873,445 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
March 4, 2026
·
10 min read
Press Releases
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor
March 4, 2026
·
6 min read
Press Releases
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
March 4, 2026
·
19 min read
Press Releases
KALA BIO Announces Strategic Initiative to Deploy and Continue to Develop an On-Premises AI Infrastructure Platform for the Biotech Industry; Enters Into Platform Development and Exclusive License Agreement for Proprietary AI Research Platform “Researgency”
March 4, 2026
·
20 min read
Press Releases
Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference
March 4, 2026
·
3 min read
Press Releases
New data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors
March 4, 2026
·
6 min read
Patents
Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant
The settlement value, which includes a $950 million upfront payment plus up to $1.3 billion in contingent commitments, is an outcome “better than feared,” according to analysts.
March 4, 2026
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
Sanofi will gain global exclusive rights over rovadicitinib, an oral JAK/ROCK blocker that has anti-inflammatory and anti-fibrotic effects.
March 4, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 4, 2026
·
61 min read
·
BioSpace Editorial Staff
Press Releases
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments
March 4, 2026
·
6 min read
1 of 87,345
Next
